report_lead_image_with_gradient.png
2025

EMEA Healthcare Market Snapshot

Download this Report
To download this report, please complete the form below

PitchBook clients can access this report’s Excel data pack via the Research Center on the PitchBook Platform.

Isomorphic Labs, Neko Health lead surge in EMEA healthtech unicorns

Healthcare VC and PE dealmaking in EMEA is heating up, with Q1 marking a two-year high in deal value and signalling renewed investor appetite. A wave of mega-rounds—led by Isomorphic Labs, Verdiva Bio, Neko Health, and AMBOSS—has reignited momentum in the region, especially in biopharma and medtech. Investors are doubling down on AI-driven diagnostics, surgical robotics, and remote monitoring platforms, reinforcing Europe’s positioning as a global hub for healthcare innovation.

While shares of public healthcare stocks in EMEA have been volatile, venture activity is on the rise, and new unicorns are emerging in key cities such as London, Paris, Cambridge, and Tel Aviv. European policymakers are also stepping in, launching ambitious funding initiatives to attract top research talent amid waning US public-sector support. All signs point to the EMEA region emerging as a central hub for healthcare research & development, dealmaking, and startup growth in 2025 and beyond.


Table of contents
Commentary 1
City comparison 5
Public markets 6
VC activity 7
PE activity 10
Fundraising 11